Annals of Nuclear Medicine - Best Paper Hisada Prize Winners
As the 2023 Award for the Best Three Papers (Hisada Prize) selected from the Annals of Nuclear Medicine, the JSNM Board of Directors has selected:
Gold Prize
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma (this opens in a new tab)
Annals of Nuclear Medicine 2022, 36(3), 267 - 278.
Anri Inaki, et al
Silver prize
Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study (this opens in a new tab)
Annals of Nuclear Medicine 2022, 36(12), 1039 - 1049.
Hiroshi Matsuda, et al
Bronze Prize
[18F]FDG uptake in axillary lymph nodes and deltoid muscle after COVID-19 mRNA vaccination: a cohort study to determine incidence and contributing factors using a multivariate analysis (this opens in a new tab)
Annals of Nuclear Medicine 2022, 36(4), 340 - 350.
Kazuo Kubota, et al
